Browse by CV

Up a level
Export as [feed] Atom [feed] RSS

HURST, L. A., BUNNING, R. A. D., COURAUD, P.-O., ROMERO, I. A., WEKSLER, B. B., SHARRACK, B. and WOODROOFE, M. N. (2009). Expression of ADAM-17, TIMP-3 and fractalkine in the human adult brain endothelial cell line, hCMEC/D3, following pro-inflammatory cytokine treatment. Journal of neuroimmunology, 210 (1-2), 108-112.

REID, M. J., CROSS, A. K., HADDOCK, G., ALLAN, S. M., STOCK, C. J., WOODROOFE, M. N., BUTTLE, D. J. and BUNNING, R. A. D. (2009). ADAMTS-9 expression is up-regulated following transient middle cerebral artery occlusion (tMCAo) in the rat. Neuroscience letters, 452 (3), 252-257.

TURNER, S. L., BLAIR ZAJDEL, M. E. and BUNNING, R. A. D. (2009). ADAMs and ADAMTSs in cancer. British journal of biomedical science, 66 (2), 117-128.

CROSS, A. K., HADDOCK, G., STOCK, C. J., ALLAN, S., SURR, J., BUNNING, R. A., BUTTLE, D. J. and WOODROOFE, N. (2006). ADAMTS -1 and -4 are up-regulated following transient middle cerebral artery occlusion in the rat and their expression is modulated by TNF in cultured astrocytes. Brain research, 1088 (1), 19-30.

MBVUNDULA, E. C., BUNNING, R. A. D. and RAINSFORD, K. D. (2005). Arthritis and cannabinoids: HU-210 and Win-55,212-2 prevent IL-1α-induced matrix degradation in bovine articular chondrocytes in-vitro. Journal of pharmacy and pharmacology, 58 (3), 351-358.

PLUMB, J., MCQUAID, S., CROSS, A. K., SURR, J., HADDOCK, G., BUNNING, R. A. D. and WOODROOFE, M. N. (2005). Upregulation of ADAM-17 expression in active lesions in multiple sclerosis. Multiple Sclerosis, 12 (4), 375-385.

MBVUNDULA, E. C., BUNNING, R. A. D. and RAINSFORD, K. D. (2004). Effects of cannabinoids on nitric oxide production by chondrocytes and proteoglycan degradation in cartilage. Biochemical pharmacology, 69 (4), 635-640.

GODDARD, D. R., BUNNING, R. A. D. and WOODROOFE, M. N. (2001). Astrocyte and endothelial cell expression of ADAM 17 (TACE) in adult human CNS. Glia, 34 (4), p. 267.

This list was generated on Tue Sep 29 10:23:20 2020 UTC.